Vaginal Biome Science, Inc.

EUGENE, OR · Founded 2021 · Biotech · Private

microbiome-based vaginal health diagnostics and therapeutics

Claim this profile

Follows are private to you and power your alerts

Updated · vaginalbiomescience.com

Sector
Biotech
Headquarters
EUGENE, OR
Founded
2021
Latest Form D
$3.1M, Jul 2022
Total capital
$3.1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$3.1M
1 Form D · last Jul 2022
51 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
9 pending · first 2023
Rank in peer group#339 of 1449

Capital timeline

2022FEDERAL ↑EQUITY ↓Cumulative $3.1M1st Form D$3.1M
2022FEDERAL ↑EQUITY ↓Cumulative $3.1M1st Form D$3.1M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$3.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#339 · top 23%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Gary Harrison GuseinovDirectorNamed in SEC Form D filings
  • Jane David MillerDirectorNamed in SEC Form D filings
  • Luke Vincent StrgarDirectorNamed in SEC Form D filings
  • Michael Harrison JonesDirectorNamed in SEC Form D filings
  • Tom Harrison ZelenovicDirectorNamed in SEC Form D filings
  • Wendy Orlow-StrgarExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 12
Show all 12 patent records
  • Composition For Personal Care ProductsDec 18, 2025 · Application 19240577Pending
  • Topical Fertility Promoting Product And Manufacturing MethodSep 16, 2025 · US 12,414,926Granted
  • Topical Substance For Vaginal UseFeb 18, 2025 · US 12,226,378Granted
  • System, Product And Method For Maintaining The Vaginal MicrobiomeApr 18, 2024 · Application 18539018Pending
  • Topical Fertility Promoting Product And Manufacturing MethodNov 7, 2023 · US 11,806,325Granted
  • System, Product And Method For Maintaining The Vaginal MicrobiomeApr 27, 2023 · Application 18048761Pending
  • System, Product And Method For Maintaining The Vaginal MicrobiomeApr 27, 2023 · Application 18048762Pending
  • Salt Balanced Vaginal Product And MethodMar 21, 2019 · Application 16191221Pending
  • System, Product And Method For Maintaining The Vaginal MicrobiomeApplication PCTUS2022078540Pending
  • Topical Substance For Vaginal UseApplication 63660769Pending
  • Composition For Personal Care ProductsApplication PCTUS2025033973Pending
  • System, Product And Method For Maintaining The Vaginal MicrobiomeApplication 63271021Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .